Edgar Tracker

GILD GILEAD SCIENCES, INC.

Nasdaq · CIK 882095 · Biological Products, (No Diagnostic Substances)

SEC company page

Public articles

No public articles yet. Follow GILD to track filings and write notes.

Recent filings

–

Form Filed Title Accession
N-PX2026-08-26—0001123292-26-001172
SCHEDULE 13D/A2026-08-07—0001104659-26-092737
S-3ASR2026-08-06S-3ASR0001104659-26-092110
10-Q2026-08-06FORM 10-Q0000882095-26-000031
8-K2026-08-042.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0000882095-26-000028
13F-HR2026-08-03—0001123292-26-001034
SCHEDULE 13D/A2026-05-27—0001123292-26-000750
8-K2026-05-201.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001104659-26-064518
424B52026-05-18424B50001104659-26-063199
FWP2026-05-14FWP0001104659-26-061317
424B52026-05-14424B50001104659-26-060745
13F-HR2026-05-08—0001123292-26-000642
S-82026-05-07FORM S-80000882095-26-000025
10-Q2026-05-07FORM 10-Q0000882095-26-000024
8-K2026-05-072.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits0000882095-26-000022
8-K2026-05-045.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and Exhibits0000882095-26-000008
SCHEDULE 13G2026-04-29—0002100119-26-000510
SCHEDULE 13D/A2026-04-28—0001104659-26-049902
8-K2026-04-287.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits0001104659-26-049874
SC TO-T/A2026-04-28SC TO-T/A0001104659-26-049870